Voronoi (310210) stock
KOSDAQ · Pharmaceuticals
As of Nov 16, 1:01 PM KST
- Market cap
- KRW 1.9 trillion
- As of Nov 16, 2026
- P/E
- -27.39x
- Trailing twelve months
- P/B
- 27.37x
- Latest reported equity
- P/S
- 252.03x
- Trailing twelve months
- ROE
- -99.9%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
- Market cap
- KRW 1.9 trillion
- As of Nov 16, 2026
- P/E
- -27.39x
- Trailing twelve months
- P/B
- 27.37x
- Latest reported equity
- P/S
- 252.03x
- Trailing twelve months
- ROE
- -99.9%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
-27.39x
Net loss — not comparable
P/B
27.37x
P/S
252.03x
Earnings and dividend metrics▾
Earnings
EPS
-KRW 3,714
Earnings per share
BPS
KRW 3,716
Book value per share
ROE
-99.9%
Return on equity
- EPS — what one share earned over the last four quarters. The company is currently loss-making, at KRW 3,714 per share.
- BPS — net assets divided by the number of shares. Each share is backed by KRW 3,716 of net assets.
- ROE — shareholder equity shrank by 99.9% over a year.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from DART financial filings: net income attributable to owners of the parent and revenue are summed over the latest four quarters, equity is the latest reported equity, and prices are KRX closing prices.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Earnings
Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| Q2 2026Consolidated · Filed Oct 2, 2026 | — | -KRW 29.3 billion | -KRW 29 billion | — |
| Q1 2026Consolidated · Filed May 15, 2026 | — | -KRW 22 billion | -KRW 22 billion | — |
| Q4 2025Consolidated · Filed Mar 20, 2026 | KRW 0 | -KRW 16.2 billion | -KRW 4.3 billion | — |
| Q3 2025Consolidated · Filed Nov 14, 2025 | KRW 4.1 billion | -KRW 13.6 billion | -KRW 13.8 billion | — |
| H1 2025Consolidated · Filed Aug 14, 2025 | KRW 3.4 billion | -KRW 24.6 billion | -KRW 24.6 billion | — |
| Q1 2025Consolidated · Filed May 9, 2025 | — | -KRW 14.5 billion | -KRW 14.1 billion | — |
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| FY2025Consolidated · Filed Mar 20, 2026 | KRW 7.5 billion | -KRW 54.4 billion | -KRW 42.7 billion | — |
| FY2024Consolidated · Filed Mar 20, 2025 | — | -KRW 36.3 billion | -KRW 32.6 billion | — |
- Q2 2026 is computed as H1 2026 minus Q1 2026.
- Q4 2025 is computed as FY2025 minus 9M 2025.
- Q3 2025 is computed as 9M 2025 minus H1 2025.
- Year-to-date rows are cumulative from the start of the fiscal year.
Short selling and securities lending
Short sales as a share of trading value, the reported short position and the securities lending balance.
- Short-sale share
- 7.45%
- Of trading value on Nov 13, 2026
- Short-sale value
- KRW 940 million
- Previous 20-day average 11.10%
- Net short position
- 401,557 shares
- As of Nov 11, 2026 · reported with a two-trading-day lag
- Lending balance
- 1,691,197 shares
- As of Nov 13, 2026 · 9.08% of listed shares
| Date | Share | Value |
|---|---|---|
| Nov 13, 2026 | 7.45% | KRW 940 million |
| Nov 12, 2026 | 16.60% | KRW 1.37 billion |
| Nov 11, 2026 | 10.86% | KRW 1.22 billion |
| Nov 10, 2026 | 14.94% | KRW 1.69 billion |
| Nov 9, 2026 | 9.56% | KRW 820 million |
| Nov 6, 2026 | 4.75% | KRW 550 million |
| Nov 5, 2026 | 12.78% | KRW 1.25 billion |
| Nov 4, 2026 | 9.12% | KRW 1.71 billion |
| Nov 3, 2026 | 16.33% | KRW 2.03 billion |
| Nov 2, 2026 | 9.88% | KRW 730 million |
The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.
Filings
Major filings received by DART, Korea’s regulatory filing system.
- Decision on Convertible Bond Issuance(Korean)Nov 13, 2026 · Bond Issuance
- Technology or Regulatory ApprovalNov 10, 2026English
- Technology or Regulatory Approval(Korean)Oct 20, 2026
- Decision on Early Acquisition of Own Convertible Bonds(Korean)Oct 8, 2026 · Bond Issuance
- Technology or Regulatory Approval(Korean)Sep 18, 2026
- Technology or Regulatory Approval(Korean)Sep 14, 2026
- Technology or Regulatory Approval(Korean)Sep 9, 2026
- Technology or Regulatory Approval(Korean)Sep 9, 2026
Filings with a published English version open in English; the rest link to the Korean original.
Voronoi (310210) stock information
KOSDAQ
Voronoi (310210) is listed on KOSDAQ. Its market capitalization is about KRW 1.9 trillion. On trailing-twelve-month earnings the P/E ratio is -27.39, and the P/B ratio is 27.37. Return on equity is -99.9%. These figures are computed in-house from official filings and are reference information only.
Voronoi — frequently asked questions
- What is the P/E ratio of Voronoi (310210)?
- On a trailing-twelve-month basis, 310210 trades at a P/E ratio of -27.39. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Voronoi?
- 310210 has a market capitalization of about KRW 1.9 trillion. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.